A Polypill for All? Critical Review of the Polypill Literature for Primary Prevention of Cardiovascular Disease and Stroke

Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects

(2011) Paul Muntner et al.   AMERICAN HEART JOURNAL

Chlorthalidone Reduces Cardiovascular Events Compared With Hydrochlorothiazide

(2011) Michael P. Dorsch et al.   HYPERTENSION

An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk

(2011)   PLoS One

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization

(2011) Elsayed Z Soliman et al.   Trials

Preservation of Bioavailability of Ingredients and Lack of Drug-Drug Interactions in a Novel Five-Ingredient Polypill (Polycap™)

(2010) Anil Patel et al.   American Journal of Cardiovascular Drugs

A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (‘polypill’) on cardiovascular risk factors

(2010) F. Malekzadeh et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled Trial

(2010) F. Gerald R. Fowkes   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

(2009)   LANCET

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk

(2008) Jacoba P. Greving et al.   CIRCULATION

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

(2008) Hisao Ogawa   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Relation of Beta-Blocker–Induced Heart Rate Lowering and Cardioprotection in Hypertension

(2008) Sripal Bangalore et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY